Groups and subgroups (n) Glutathione peroxidase, s.u. Glutathione reductase, s.u. Total antioxidant activity, % SH-groups, mmol/l
to treatment After two months to treatment after two months to treatment after two months to treatment after two months
1 (n=74) 3.416 ± 0.09295#© 4.562 ± 0.1207#©* 134.7 ± 1.911#© 191 ± 5.150#©* 20.72 ± 0.5031#© 37.93 ± 1.674#©* 3.852 ± 0.1389#© 5.969 ± 0.1706#©*
1А (n=41) 3.139 ± 0.09942©@■ 4.216 ± 0.1218©*@■ 130.7 ± 2.478©@■ 176 ± 5.860©*@■ 19.44 ± 0.5037©@■ 33.95 ± 1.327©*@■ 3.259 ± 0.1587©@■ 5.439 ± 0.1888©*@■
1B (n=33) 3.762 ± 0.1488©¢® 4.993 ± 0.2026©*¢® 139.6 ± 2.785©¢® 209.7 ± 7.911 α*¢® 22.30 ± 0.8709©¢® 42.88 ± 3.197©*¢® 4.588 ± 0.1703©¢® 6.627 ± 0.263α*¢®
2 (n=66) 4.128 ± 0.1058© 5.390 ± 0.1280©* 148.6 ± 3.310© 228.7 ± 5.461α* 24.65 ± 0.6289© 51.44 ± 1.838©* 4.883 ± 0.1549© 7.989 ± 0.2162©*
2А (n=15) 3.676 ± 0.1637©● 4.726 ± 0.1624©*● 140.6 ± 3.604©● 206.3 ± 9.687α*● 22.20 ± 1.092©● 39.53 ± 1.502©*● 4.134 ± 0.2883©● 7.073 ± 0.3317α*●
2B (n=51) 4.261 ± 0.1227©¤ 5.585 ± 0.1485©*¤ 150.9 ± 4.109©† 235.2 ± 6.217α*¤ 25.37 ± 0.7222©¤ 54.94 ± 2.102©*¤ 5.103 ± 0.1711©¤ 8.259 ± 0.2513©*¤
3 (n=30) 6.297 ± 0.1985 217.6 ± 5.901 64.73 ± 1.1510 6.66 ± 0.2588
# - difference significant (p<0.01) when comparing between 1 and 2 group, © - difference was significantly (p<0.05) when compared with group 3, α - difference is not significant (p>0.05) when compared with group 3, * - difference was significantly (p<0.001) when compared to treatment and after 2 months between the group (subgroup), @ - significant difference (p<0.05) when comparing between 1A and 2A subgroup, ¢ significant difference (p<0.01) when Comparing between 1B and 2B subgroup, ® - significant difference (p<0.05) when comparing between 1A and 1B subgroup, ¤ - significant difference (p<0.05) when comparing between 2A and 2B subgroup, † - difference is not significant (p>0.05) when comparing between 1A and 2B subgroup, ■ - significant difference (p<0.001) when comparing between 1A and 2B subgroup, ● - the difference is not significant (p>0.05) when comparing between the 2A and 1B subgroup
Table 2: Condition indicators antioxidant defense in patients with pulmonary tuberculosis and healthy donors (лю ± m).